Form 4 for CLVT CLARIVATE PLC
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0000950103-24-016687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-22 | 2024-11-20+ | CLVT | Angelakis Michael J | Dir | P - Purchase | $5.16 | +3.46M | 2.70M | New | +$17.86M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-20 | P | A | 1,500,000 | $5.11 | 1,500,000 | I See Footnote | — | — | (F4) The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which these transactions were effected. (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.21 inclusive. (F5) Reflects ordinary shares of Clarivate held directly by Atairos Strategic Partners, L.P. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the sole member of Atairos Strategic Partners GP, LLC, which is the general partner of Atairos Strategic Partners, L.P. (F7) Mr. Angelakis disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| 2 | Common | Ordinary Shares | 2024-11-22 | P | A | 765,000 | $5.19 | 3,465,000 | I See Footnote | — | — | (F4) The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which these transactions were effected. (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.08 to $5.25 inclusive. (F5) Reflects ordinary shares of Clarivate held directly by Atairos Strategic Partners, L.P. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the sole member of Atairos Strategic Partners GP, LLC, which is the general partner of Atairos Strategic Partners, L.P. (F7) Mr. Angelakis disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| 3 | Common | Ordinary Shares | 2024-11-21 | P | A | 1,200,000 | $5.19 | 2,700,000 | I See Footnote | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.24 inclusive. (F4) The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which these transactions were effected. (F5) Reflects ordinary shares of Clarivate held directly by Atairos Strategic Partners, L.P. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the sole member of Atairos Strategic Partners GP, LLC, which is the general partner of Atairos Strategic Partners, L.P. (F7) Mr. Angelakis disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |